Michelle R Machacek

This inventor holds 35 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 30 EPO patents, primarily in Cancer Therapeutics. Top assignees: Merck Sharp + Dohme Corp., Merck Canada Inc., Merck Sharp & Dohme LLC. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michelle R Machacek. Retrieved from https://idiyas.com/inventor/michelle-r-machacek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 35 (Patent Applications = 3)

% Patents Active = 97.1

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 30 (Patent Applications = 27)

Average Co-Inventor Count = 6.8

ph-index = 6

Forward Citations = 129(Granted Patents)

Location History:

Brookline, MA (US) (2012 - 2018)
Boston, MA (US) (2009 - 2019)
Belmont, MA (US) (2019 - 2024)

Company Filing History:

30 out of 2,405

Merck Sharp + Dohme Corp.

Merck Sharp & Dohme LLC

Msd International Gmbh

patents

where one patent can have more than one assignee

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

PRMT5 Inhibitors

Spleen Tyrosine Kinase

HDM2 Inhibitors

Janus Kinases

Tricyclic Compounds

Thiazole-Substituted

Amino-Pyrimidines

Pyrazolyl Derivatives

Quinolinone PDE2

Aminopyrimidines

Substituted Imidazopyridines

Aminopyridine-Containing

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12595262 - PRMT5 inhibitors (2026-04-07),

2. 12595248 - PRMT5 inhibitors (2026-04-07),

3. 12583871 - PRMT5 inhibitors (2026-03-24),

4. 12552826 - PRMT5 inhibitors (2026-02-17),

5. 12441730 - PRMT5 inhibitors (2025-10-14),

6. 12173026 - PRMT5 inhibitors (2024-12-24),

7. 11993602 - PRMT5 inhibitors (2024-05-28),

8. 11981701 - PRMT5 inhibitors (2024-05-14),

9. 11098059 - PRMT5 inhibitors (2021-08-24),

10. 10947234 - PRMT5 inhibitors (2021-03-16),

11. 10508108 - Tricyclic compounds as inhibitors of mutant IDH enzymes (2019-12-17),

12. 10442819 - Tricyclic compounds as inhibitors of mutant IDH enzymes (2019-10-15),

13. 10086000 - Tricyclic compounds as inhibitors of mutant IDH enzymes (2018-10-02),

14. 9783531 - Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors (2017-10-10),

15. 9745295 - Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors (2017-08-29),

Title: The Innovative Journey of Michelle R Machacek

Introduction: Michelle R Machacek, a pioneering inventor based in Brookline, MA (US), has made significant contributions to the field of technology with her groundbreaking inventions.

Latest Patents: Michelle R Machacek holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing her diverse range of expertise and innovative spirit.

Career Highlights: With a background in engineering and a passion for problem-solving, Michelle R Machacek has led successful projects that have revolutionized industries. Her commitment to pushing the boundaries of innovation has earned her recognition as a trailblazer in the field.

Collaborations: Throughout her career, Michelle R Machacek has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life. Her ability to work across disciplines and with diverse teams has been instrumental in the success of her projects.

Conclusion: Michelle R Machacek's relentless pursuit of innovation and her dedication to creating solutions that make a difference have established her as a prominent figure in the world of inventors. Her impact on technology and society continues to inspire future generations of innovators.

Profile summary based on public USPTO records.